TY  - JOUR

T1  - Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo‐controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ)

JO  - British Journal of Dermatology

UR  - http://eprints.whiterose.ac.uk/125021/

PY  - 2018/05/01

AU  - de Bruin-Weller M

AU  - Thaçi D

AU  - Smith CH

AU  - Reich K

AU  - Cork M

AU  - Radin A

AU  - Zhang Q

AU  - Akinlade B

AU  - Gadkari A

AU  - Eckert L

AU  - Hultsch T et al

ED  - 

DO  - DOI: 10.1111/bjd.16156

VL  - 178

IS  - 5

SP  - 1083

EP  - 1101

Y2  - 2024/12/22

ER  -